As of mid-2025, dengue fever is surging worldwide, with alarming increases reported in Southeast Asia, Latin America, and parts of Africa. According to the World Health Organization (WHO), over 6 million cases have been reported globally in the first half of the year, many of which resulted in hospitalization and severe complications. Rapid identification and timely intervention are critical in controlling outbreaks and reducing mortality. In this context, accurate and rapid diagnostic solutions are essential. The Bioteke Dengue NS1/IgG/IgM Rapid Test Kit provides an efficient, cost-effective solution for early detection and differentiation of dengue infections at the point of care.
As modern women's demand for a more convenient, comfortable and private way to confirm pregnancy continues to grow, Bioteke has launched a saliva pregnancy test kit - a breakthrough alternative to traditional urine tests. This innovative product detects human chorionic gonadotropin (hCG) in s
Bioteke Joins Global Efforts to Promote IVD Quality and SafetyWuxi, China – June 27, 2025 – In response to the World Health Organization’s third annual “Week of Quality for In Vitro Diagnostics” (IVD Quality Week), Bioteke Corporation is proud to highlight its ongoing commitment to international dia
Important certification: This product has obtained the EU IVDR (In Vitro Diagnostic Medical Device Regulation) CE‑3018 self-test certification on May 30, 2025, and is officially allowed to be sold in the EU/EEA as a home self-test